Oral povorcitinib promising in extensive nonsegmental vitiligo at week 52 in Phase 2b clinical trial Written By Dr. Kamal Kant Kohli26 Oct 2023 10:30 AM ISTUSA: Treatment with oral povorcitinib in adult patients with extensive nonsegmental vitiligo was associated with substantial total body and facial...
Early diagnosis of 'chemical' or chemically aggravated vitiligo improves prognosis Written By Jacinthlyn Sylvia12 Jan 2023 8:00 PM ISTA new study by Nada Kotti and team showed that a major contributing component to the vitiligo incidence is chemical variables. The findings of this...
Inflammatory bowel disease associated with chronic inflammatory skin diseases Written By Dr.Niharika Harsha B9 Dec 2022 8:00 PM ISTA new study revealed that inflammatory bowel disease was associated with various chronic inflammatory skin diseases. IBD incidence was increased in...
Polymorphism in Vitamin D receptors linked to development of vitiligo Written By Jacinthlyn Sylvia11 Nov 2022 8:00 PM ISTIn a new study published in Journal of Cosmetic Dermatology, it was shown that ApaI and BsmI polymorphisms in vitamin D receptor (VDR) have been...
Research Finds Vitiligo Patients May Be More Prone to Metabolic Syndrome Written By Dr. Kamal Kant Kohli4 Nov 2022 8:00 PM ISTEGYPT: According to a recent study that appeared in the Journal of Cosmetic Dermatology, vitiligo may be regarded as a risk factor for both insulin...
Ruxolitinib cream associated with higher repigmentation of vitiligo lesions, study says Written By Medha Baranwal26 Oct 2022 8:00 PM ISTUSA: Results from two phase 3 trials published in the New England Journal of Medicine showed that the application of ruxolitinib cream led to a...
Non-segmental vitiligo closely related to ocular problems: Study Written By Dr. Kamal Kant Kohli23 Sept 2022 11:15 AM ISTEgypt: Ocular alterations are more likely to occur in those with non-segmental vitiligo states a study published in the Australasian Journal of...
Disease Stability in Segmental and Non-Vitiligo-IDOJ study Written By Dr Manoj Kumar Nayak26 Aug 2022 7:30 PM ISTDisease Stability in Segmental and Non-Segmental Vitiligo-IDOJ study Disease stability in vitiligo is essential in making therapeutic decisions...
FDA approves Opzelura for repigmentation in nonsegmental vitiligo Written By Dr. Kamal Kant Kohli21 July 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult...
Guideline on diagnosis and treatment of vitiligo Written By Medha Baranwal28 March 2022 9:00 AM ISTGermany: A recent study in the Journal of the German Society of Dermatology reports S1 guidelines for the diagnosis and treatment of...
308-nm LED safe and effective treatment for vitiligo of face: Study Written By Dr. Shravani Dali19 March 2022 10:15 AM ISTThe 308-nm LED is safe and effective for the treatment of vitiligo, especially for lesions on the face and neck according to a recent study...
Common Dermatological Conditions That Present Differently in Coloured Children Written By MD Bureau10 March 2022 9:00 AM ISTPediatric patients with skin of colour, which refers to individuals with Fitzpatrick skin types III through VI, comprising many racial and ethnic...
